Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/AYALA PHARMACEUTICALS INC/ S-8 POS

SEC Filing · S-8 POS

AYALA PHARMACEUTICALS INC

ADXSNASDAQEQUITYCurrent

SEC Filing

Filed Apr 15, 2024Accepted Apr 15, 2024, 12:33 PM EDTCIK 1100397Accession 0000929638-24-001472
View company →Permanent SEC source ↗
Share

Company context

Current securities

ADXSNASDAQ · EQUITY · Current
Historical securities (1)
ADXSWNASDAQ · WARRANT · Historical · closed Oct 19, 2018

Recent company filings

  1. SCHEDULE 13G - filed by Ayala Pharmaceuticals, Inc. regarding OS Therapies IncApr 16, 2025
  2. 15-12G filingMay 9, 2024
  3. 10-K/A filingApr 26, 2024
  4. 8-K/A filingApr 19, 2024
  5. 10-K filingApr 16, 2024

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗